Pharmabiz25m
SunAct inks deal with Malaysian firm Abgentil to introduce cutting-edge cancer treatment for solid state tumours in India
SunAct inks deal with Malaysian firm Abgentil to introduce cutting-edge cancer treatment for solid state tumours in India: ...
Pharmabiz11m
Valneva submits label extension application to US FDA for chikungunya vaccine, IXCHIQ
Valneva submits label extension application to US FDA for chikungunya vaccine, IXCHIQ: Saint Herblain, France Thursday, November 28, 2024, 16:00 Hrs [IST] Valneva SE, a specialty ...
Pharmabiz40m
Exelixis updates from sNDA for cabozantinib to treat patients with previously treated advanced neuroendocrine tumours
Exelixis updates from sNDA for cabozantinib to treat patients with previously treated advanced neuroendocrine tumours: Alameda, California Thursday, November 28, 2024, 15:30 Hrs [ ...
Pharmabiz54m
BCG-OPPI Report highlights Indian healthcare market to unlock disruptive growth
BCG-OPPI Report highlights Indian healthcare market to unlock disruptive growth: Our Bureau, Bengaluru Thursday, November 28, 2024, 15:15 Hrs [IST] Organisation of Pharmaceutical ...
Pharmabiz1h
PTC Therapeutics’ phase 2 CardinALS study of utreloxastat in ALS patients fails to meet primary endpoint
PTC Therapeutics’ phase 2 CardinALS study of utreloxastat in ALS patients fails to meet primary endpoint: Warren, New Jersey Thursday, November 28, 2024, 15:00 Hrs [IST] PTC The ...
Pharmabiz2h
India’s pharma’s 79% CXOs see AI/ML as key drivers of growth: EY Parthenon–OPPI report
EY Parthenon–OPPI report: Our Bureau, Bengaluru Thursday, November 28, 2024, 13:45 Hrs [IST] EY Parthenon (EY-P ...
Pharmabiz1h
National Epilepsy Day celebrated by Epilepsy Foundation of India and the Mumbai Educational Trust
National Epilepsy Day celebrated by Epilepsy Foundation of India and the Mumbai Educational Trust: Our Bureau, Mumbai Thursday, November 28, 2024, 14:30 Hrs [IST] In a significant ...
Pharmabiz2h
Idorsia enters into exclusive negotiations with an undisclosed party for global rights to aprocitentan
Idorsia enters into exclusive negotiations with an undisclosed party for global rights to aprocitentan: Allschwil, Switzerland Thursday, November 28, 2024, 14:00 Hrs [IST] Idorsia ...
Pharmabiz1h
Fedo.ai with Electronic Village to empower health benchmarking across the GCC Region
Fedo.ai with Electronic Village to empower health benchmarking across the GCC Region: Our Bureau, Bengaluru Thursday, November 28, 2024, 14:45 Hrs [IST] Fedo.ai, an AI-driven plat ...
Pharmabiz1h
Abbott launches 14 valent pneumococcal conjugate vaccine with broad protection for children
Abbott launches 14 valent pneumococcal conjugate vaccine with broad protection for children: Our Bureau, Bengaluru Thursday, November 28, 2024, 14:15 Hrs [IST] Abbott has launched ...
Pharmabiz2h
Women in Pharma Roundtable discusses needs and challenges of women in the sector
Women in Pharma Roundtable discusses needs and challenges of women in the sector: Our Bureau, New Delhi Thursday, November 28, 2024, 13:30 Hrs [IST] CPHI & PMEC India 2024 held a ...
Pharmabiz4h
Lexicon completes patient enrollment in phase 2B PROGRESS study of LX9211 in diabetic peripheral neuropathic pain
Lexicon completes patient enrollment in phase 2B PROGRESS study of LX9211 in diabetic peripheral neuropathic pain: The Woodlands, Texas Thursday, November 28, 2024, 12:00 Hrs [IST ...